Trinity Biotech plc
Market Cap
$7.63M
P/E Ratio
-0.46
EPS
$-1.60
Dividend Yield
0.00%
52-Week Range
$0.48 — $3.44
Volume
82.92K
Avg Volume
3.40M
Beta
0.70
P/E (TTM)
-0.46
Forward P/E
—
PEG Ratio
-0.05
P/S (TTM)
0.16
P/B (TTM)
-0.26
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.81%
ROA (TTM)
-0.36%
ROIC
—
Gross Margin
0.35%
Operating Margin
-0.41%
Net Margin
—
Debt/Equity
-2.14
Current Ratio
1.03
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-9.55%
EPS Growth (5Y)
-5.62%
Sales Growth (3Y)
-0.08%
Sales Growth (5Y)
-0.06%
EPS Est (This Year)
$-1.09
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.07
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
10.39M
Float
10.02M
Free Float %
96.43%
RSI (14)
63.54
SMA 20
$0.80
SMA 50
$0.88
SMA 200
$2.09
ATR (14)
0.09
Volatility (Week)
0.08%
Volatility (Month)
0.06%
Pattern
—
1 Day
+8.75%
1 Week
+11.28%
1 Month
+18.56%
3 Months
-7.95%
6 Months
-79.14%
1 Year
—
YTD
+16.59%
All-Time High
$17.20
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
IE
Exchange
NASDAQ
IPO Date
1992-10-21
Employees
380
CEO
John Gillard
Index Membership
—
Website
https://www.trinitybiotech.com
Trinity Biotech plc (TRIB) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $7.63M, a P/E ratio of -0.46, TRIB is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare TRIB against other stocks using dozens of fundamental and technical filters.
Trinity Biotech plc (TRIB) has a trailing twelve-month (TTM) P/E ratio of -0.46. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Trinity Biotech plc (TRIB) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Trinity Biotech plc (TRIB) has a market capitalization of $7.63 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Trinity Biotech plc (TRIB) has returned +16.59% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.